Get the Stockscreener App
95.47
2.86%
-2.81
After Hours:
95.75
0.28
+0.29%
Genedx Holdings Corp stock is traded at $95.47, with a volume of 621.66K.
It is down -2.86% in the last 24 hours and up +1.07% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$98.28
Open:
$97.32
24h Volume:
621.66K
Relative Volume:
0.63
Market Cap:
$2.88B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-30.70
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
+3.08%
1M Performance:
+1.07%
6M Performance:
+70.48%
1Y Performance:
+937.72%
1-Day Range:
$92.92
$97.78
1-Week Range:
$89.16
$102.77
52-Week Range:
$8.6328
$115.60
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
888-729-1206
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
95.47 | 2.88B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand - Insider Monkey
GeneDx to enhance genomic medicine offerings with Fabric Genomics acquisition - Yahoo Finance
GeneDx to acquire AI genomics firm Fabric Genomics By Investing.com - Investing.com South Africa
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million - Benzinga
GeneDx to Acquire Fabric Genomics for Up to $51 Million - marketscreener.com
GeneDx Holdings Acquires Fabric Genomics for $33 Million - TipRanks
GeneDx stock in focus on Fabric Genomics buyout (WGS:NASDAQ) - Seeking Alpha
GeneDx to acquire AI genomics firm Fabric Genomics - Investing.com
Genedx To Acquire Fabric Genomics - MarketScreener
GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale - Yahoo Finance
Is GeneDx Holdings Corp. (NASDAQ:WGS) Trading At A 31% Discount? - simplywall.st
GeneDx holdings CEO Katherine Stueland sells $4.18 million in stock By Investing.com - Investing.com South Africa
GeneDx CFO Kevin Feeley sells $1.43 million in stock By Investing.com - Investing.com South Africa
GeneDx holdings CEO Katherine Stueland sells $4.18 million in stock - Investing.com Australia
GeneDx CFO Kevin Feeley sells $1.43 million in stock - Investing.com
GeneDx Holdings Corp. Executives Sell Shares - TradingView
GeneDx Q1 2025 Earnings Coming: Key Financial Results Set for April 30 - Stock Titan
GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025 - Yahoo Finance
Why GeneDx Holdings Shares Are Under Pressure - TipRanks
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - Yahoo Finance
Prudential Financial Inc. Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx CEO Stueland sells $4.45 million in stock - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock By Investing.com - Investing.com Australia
GeneDx holdings CFO Kevin Feeley sells $836,210 in stock - Investing.com India
GeneDx Holdings Corp. Executives Sell Shares to Cover Tax Obligations - TradingView
GeneDx CEO Stueland sells $4.45 million in stock By Investing.com - Investing.com UK
Victory Capital Management Inc. Acquires Shares of 2,720 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
7 Up-and-Coming Stocks to Buy in 2025 - US News Money
How To Trade (WGS) - news.stocktradersdaily.com
3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2% - simplywall.st
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now? - Insider Monkey
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $96,416.32 in Stock - MarketBeat
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -March 20, 2025 at 04:52 pm EDT - Marketscreener.com
GeneDx Strengthens Team: 10 New Hires Receive Strategic Stock Awards Worth 46,340 RSUs - Stock Titan
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Zacks.com featured highlights DRDGOLD, GeneDx, EverQuote, HCI Group and Alibaba - Yahoo Finance
12 High Growth Low Debt Stocks to Invest in Now - Insider Monkey
Is Now The Time To Look At Buying GeneDx Holdings Corp. (NASDAQ:WGS)? - Yahoo Finance
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies - Yahoo Finance
GeneDx Revolutionizes Genome Sequencing with 48-Hour Results, Earns Top Innovation Honor - Stock Titan
GeneDx Holdings Corp. Executives Sell Shares for Tax Obligations - TradingView
Is GeneDx Holdings (NASDAQ:WGS) Using Too Much Debt? - Simply Wall St
Raymond James Financial Inc. Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
3,501 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Arizona State Retirement System - Defense World
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Short Interest in GeneDx Holdings Corp. (NASDAQ:WGSWW) Drops By 43.2% - Defense World
Is GeneDx Holdings Corp. (WGS) the Best Multibagger Stock to Buy in 2025? - Insider Monkey
Revolutionary AI Tool by GeneDx Transforms Genetic Testing with 750,000 Clinical Sequences - StockTitan
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis - Yahoo Finance
GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich (NASDAQ:WGS) - Seeking Alpha
Genedx CFO Kevin Feeley sells shares worth $87k By Investing.com - Investing.com Australia
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 09 '25 |
Option Exercise |
32.67 |
1,246 |
40,707 |
17,242 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 09 '25 |
Sale |
92.18 |
15,516 |
1,430,334 |
1,726 |
| Stueland Katherine | Chief Executive Officer |
Apr 09 '25 |
Sale |
89.62 |
46,594 |
4,175,817 |
1,720 |
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):